SGHT Articles, Sight Sciences Inc. - From 09/12/23

RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the sto...

  Acelyrin, Inc. (NASDAQ: SLRN) shares fell 58.5% to $11.58 in pre-market trading as the company said primary endpoint of HiSCR75 at week 16 ...

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session. Ace...

Sight Sciences, Inc. (NASDAQ: SGHT) shares traded lower Monday after the company issued third-quarter total revenue guidance below estimates and cu...

MENLO PARK, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences," or the "Company"), an eyecare techn...

Sight Sciences is poised to seize a vast market opportunity with its unique and effective approved product offerings. It has also shown remarkable revenue growth over the last few years, making it a Company worth tracking.